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Abstract 
 
Introduction: High altitude environments lead to a significant physiological challenge and 
disease processes which can be life threatening; operational effectiveness at high altitude can 
be severely compromised. The UK military research is investigating ways of mitigating the 
physiological effects of high altitude 
 
Methods: The British Service Dhaulagiri Research Expedition took place from March to May 
2016, and the military personnel were invited to consent to a variety of study protocols 
investigating adaptation to high altitudes and diagnosis of high altitude illness. The studies 
took place in remote and austere environments at altitudes of up to 7500m. 
 
Results: This paper gives an overview of the individual research protocols investigated, the 
execution of the expedition and the challenges involved. 129 Servicemen and women were 
involved at altitudes of up to 7500m; 8 research protocols were investigated. 
 
Conclusions: The outputs from these studies will help to individualise the acclimatisation 
process and inform strategies for pre-acclimatisation should troops ever need to deploy at 
high altitude at short notice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Introduction 
 
The UK military runs a programme of adventurous training (AT) with the aims of promoting, 
“through the conduct of arduous outdoor activities with exposure to hardship and danger, the 
Army’s core values, leadership, teamwork and other qualities necessary to enhance the 
Operational effectiveness of all military personnel” [1] In a quadrennial cycle the Single 
Service mountaineering clubs, in rotation, lead a major expedition as an inspirational AT 
activity. This is usually, but not exclusively, a mountaineering expedition to one of the world’s 
fourteen 8,000m peaks (located in the Himalayan range in Nepal and Pakistan). The 2016 
expedition was a Royal Navy-led trip and the opportunity was taken to mount a significant 
medical research expedition to the Dhaulagiri region of Nepal - the British Services Dhaulagiri 
Medical Research Expedition (BSDMRE) 2016. The expedition had support of His Royal 
Highness the Duke of York and the Surgeon General. 
 
This journal has previously published on the challenges and opportunities of research in high 
altitude environments and on the potential benefits of AT.[2, 3] This research expedition was 
part of ongoing UK military and civilian research with collaboration between the Royal Centre 
for Defence Medicine (RCDM), Leeds Beckett University and the University of Oxford. The 
studies focussed on the physiological response to high altitude (HA), the diagnosis of acute 
mountain sickness (AMS) and strategies to enable the rapid deployment of troops to a HA 
environment (pre-acclimatisation). This article describes the background to these studies and 
the research protocols used and acts as a foundation for subsequent publication of specific 
study results. 
 
 
Methods 
 
Funding 
 
AT is formal, publicly funded military training. Participation in AT is “an integral aspect of 
military training that supports the values and standards of the military thus enhances an 
individual’s ability to withstand the rigours of operations”.[1] This direct public funding 
contributed around 50% of the costs for each subject which in turn facilitated the relatively 
large numbers for a research expedition. Research funding was supported by industry 
(Medtronic Reveal Linq devices provided free of charge), public funding through RCDM, 
funding from Leeds Beckett University, University of Oxford, the Mount Everest Foundation 
and a grant from the Royal Navy Royal Marines Charity (RNRMC). It is exceptional for the 
RNRMC to support research in this way but a large fundraising event with the support of the 
  
Duke of York enabled the charity to raise sufficient funds to underwrite the research costs. 
Additional support with kit and equipment was provided by expedition sponsors notably Honda 
generators and Solarpod equipment to power the research kit described in the protocols. 
 
Environment 
 
For the initial part of the trek of the Dhaulagiri circuit the terrain was at low altitude (although 
daily ascent was considerable) and through hot, humid pasture and rainforest. From Italian 
Base camp (IBC) onwards the trek followed glaciated terrain around the western and northern 
aspects of Dhaulagiri. This terrain was dry and hot during the day and cold at night. 
Temperatures in the Hidden Valley (at 5140m) were frequently around -10ºC by night with 
considerable wind chill. By day temperatures in the direct sun or inside tents could be as high 
as +30ºC. Above IBC all precipitation fell as snow due to the low temperatures, whereas IBC 
itself experienced heavy afternoon rain storms during the latter part of the expedition. All 
research took place in tents as there is no hard accommodation on the circuit above IBC, and 
frequently early in the morning to take measurements in the starved state. This placed a great 
strain on the research teams who had to work in extreme temperatures, often clad in one piece 
down suits! 
 
Research Protocols 
The pathophysiology of HA illness remains ill-defined but the rate of AMS among military 
personnel ascending to HA as part of AT is significant, with 34% of those ascending Mount 
Kenya suffering severe AMS in one report. [4] AMS was also a significant cause of Disease 
Non-Battle Injury (DNBI) during the Battle of Taku Ghar in Afghanistan in 2002 with 18 cases 
of AMS requiring casevac from theatre of operations and treatment by 274th Field Surgical 
Team.[5] The programme of research on the expedition was aimed at enhancing our 
understanding of the pathophysiology of HA exposure and AMS and answering some of the 
questions raised previously in this journal.[6] The following submissions were made to the 
MoD Research Ethics Committee (MoDREC); 
 
Protocol 578, Cardiovascular adaptation and recovery in chronic hypoxia. We have previously 
assessed various methods of recording heart rate variability at HA [7] and this study aimed to 
collect data on all the trekking teams, investigating changes in a range of physiological 
variables including heart rate variability (HRV), central aortic blood pressures and pulmonary 
artery pressures. 
 
  
Protocol 580, Utility of BNP in diagnosing Acute Mountain Sickness (AMS). We have previous 
published that brain natriuretic peptide (BNP) may have utility in the diagnosis of altitude 
illness.[8-11] This study aims to recruit subjects who become unwell on expeditions at HA over 
the next few years. This will enable us to establish whether BNP can be used to discriminate 
between those with AMS or other conditions. 
 
Protocol 608, The effects of progressive High Altitude on the development and burden of 
significant cardiac arrhythmias using an implantable Cardiac Monitor (REVEAL Study). This 
study used a small implantable (into the subcutaneous fat of the upper chest) cardiac 
monitoring device, a “Reveal LINQ” made by Medtronic. This has the capability to record and 
store information about heart rate and rhythm that can then be downloaded to a hard drive for 
subsequent analysis. The marked hypoxaemia that occurs at altitude could be arrhythmogenic 
and significant cardiac morbidity is known to occur at HA. This work builds on a smaller study 
using the predecessor to the current Reveal device that suggested significant arrhythmias do 
occur at HA.[12] 
 
Protocol 624 Appetite responses during a high altitude expedition. Very little is known about 
the underlying mechanisms regarding the anorexia and nausea suffered at HA, a topic 
previously reviewed in this journal.[13] Reductions in appetite contribute to the degradation 
that ultimately impairs performance at HA. This project investigated nutritional changes at 
HA using food diaries, an assessment of gut hormones involved in appetite regulation and the 
novel use at HA of wearable technology assessing continuous subcutaneous interstitial 
glucose levels. 
 
Protocol 623 Biomechanical changes in walking gait and balance at altitude. Changes in 
balance may occur at HA and it has been suggested that changes in balance and walking 
style may be related to the development of AMS and to the incidence of falls and accidents 
on expeditions. This research examined joint position sense, balance and coordination 
through a series of assessments including video assessment of gait and balance using a force 
platform. 
 
Protocol 663 Effects of iron status, manipulated using intravenous iron, on cardiopulmonary 
physiology during ascent to very high altitude, assessed using echocardiography and self-
reported functional performance scores. Exposure to the hypoxia of altitude leads to many 
physiological changes and a key feature is hypoxic pulmonary vasoconstriction (HPV). HPV 
increases pulmonary artery systolic pressure (PASP) and contributes to right ventricular strain 
  
and exaggerated HPV is a feature of High Altitude Pulmonary Oedema. (HAPE). This study 
used an intravenous iron infusion to optimise iron stores which at sea-level is known to 
attenuate the HPV response to hypoxia.[14] There has been one previous trial that has also 
shown a reduction in AMS following intravenous iron.[15] Participants were randomised to 
receive iron or placebo and echocardiography used to assess their PASP in the field, while 
Lake Louise scores collected allow researchers to assess any difference in AMS rates. 
 
Protocol 586 Acclimation and acclimatisation: The effects of Exercise under Normobaric 
(normal pressure) Hypoxic (reduced Fi02) conditions. We have been investigating the utility 
of “pre-acclimatisation” in a hypoxic chamber in order to establish if such exposure can 
improve performance on deployment to HA and reduce HA illness. This protocol compare the 
effects of 5 days in a normobaric hypoxic chamber at simulated altitudes of between 4300 and 
4800m with a control group. Echocardiographic variables, biochemical and endocrine markers 
of physiological stress and indices of respiratory variables representing acclimatisation were 
assessed pre- and post-hypoxic exposure as well as during the expedition in order to elucidate 
any benefit. Additionally, rates of AMS have been assessed in the field to see if prior 
acclimation can reduce the threat from HA illness. 
Protocol 625 Application of Apnoeic training and physiological adaptations to altitude. 
Free-divers expose themselves to periods of apnoea and prepare for this by a relatively simple 
method of “breath-holding”. Apnoea training induces changes that could potentially be of 
benefit at HA, including an increase in haematocrit, haemoglobin, erythropoietin and oxygen 
saturation.[16] This protocol will employ a 6 week breath hold training programme and 
compared this with a control group. Variables were assessed in the normobaric hypoxic 
chamber pre-departure at a simulated 4800 m and while on the trek. These assessments 
included spleen volume, oxygen saturation, haemoglobin, haematocrit, erythropoietin and 
rates of AMS. Both protocol 586 and 625 benefit from access not only to the fixed normobaric 
chamber at Leeds Beckett University but also a portable hypoxic chamber purchased with a 
grant from Joint Medical Command via the DMS Research Steering Group. 
 
Protocols were submitted to the RAF Scientific Advisory Committee (SAC) and subsequently 
MoDREC during 2014 to ensure plenty of lead in time and that projects could be in place prior 
to recruiting participants for the AT activity. The researchers acknowledge the efforts and 
diligence of both the SAC and MODREC, whose input significantly enhanced the scientific 
work proposed. Working with sports science specialists at Leeds Beckett University allowed 
civilian colleagues to make use of an exceptional opportunity for research of this nature and 
the military researchers to gain from their expertise and equipment. A recce to the area and 
  
limited research conducted during February 2015 were hugely useful in finalising research 
plans and resulted in some limited amendments to protocols. 
 
Participants were all members of HM Forces taking part in an AT exercise and on duty. 
Selection for this expedition was via Defence Instructions and Notices advertising the event, 
advertisement through military climbing clubs and via word of mouth. Trekking teams were 
selected by individual leaders and not by the overall expedition leadership or Principle 
Investigators. Climbing teams were selected on the basis of previous climbing experience. 
The climbers were split onto a main team of 12 experienced mountaineers to climb Dhaulagiri 
and a high altitude development team (HADT), of 12 less experienced high altitude 
mountaineers to climb Tukuche peak and gain experience. Once involved in the expedition 
participants were invited to take part in specific research studies. Participants were invited to 
participate in studies depending on time availability and geographical location before written 
informed consent was obtained. Where teams were used as controls for an intervention group 
every effort was made to match military backgrounds of individuals to ensure similar levels of 
fitness. 
 
All participants received a brief on mountain health including AMS and the military policy of 
not using prophylactic acetazolamide (Diamox®) in this setting. Baseline data was collected 
in the UK by a suitably qualified researcher before any pre-acclimatisation training took place. 
 
On the expedition, data was collected by the subjects (daily diaries) and then at three research 
camps established for the duration of the expedition at 3600m (IBC) , 4600m (Dhaulagiri BC) 
and 5140m in the Hidden Valley. These camps had resident staff of two trained researchers 
with at least one medically qualified in each location; additional researchers (military or Leeds 
Beckett staff) accompanied specific trekking teams to collect specialist data (continuous 
glucose measurements, cardiac echo, spleen ultrasound and conduct balance testing). 
 
Climbing teams had background data collected at the time of Reveal LINQ device insertion or 
when enrolled in the iron study. Any potential subject who could not comply with these timings 
(usually for service reasons) were not included in these studies although data was collected 
for non-intervention studies. All participants were low altitude dwellers, no trekking team 
members had exposure to >1500m terrestrial altitude in the four weeks prior to the studies. 
 
Research protocols undertaken by the climbers were developed mindful of minimising the 
impact of research data collection when in country. All team members flew to Kathmandu via 
long haul international flights and baseline data was collected the day after arrival or after 4 
  
days in Kathmandu in the case of the advance party. This involved recording symptoms, SpO2 
(Nonin Onyx, Nonin Medical Inc, Plymouth, Minnesota), haemaglobin (Haemocue, Haemocue 
AB, Angelholm, Sweden), cardiac function and pulmonary artery pressures (Vivid I, GE 
Healthcare, Amersham, UK) and was completed by one experienced cardiologist blinded to 
the intervention (in the case of the iron study). The team then moved to 2750m by road, where 
a further data collection period took place (day 4). After day 4 all altitude changes where 
accomplished on foot carrying moderate loads (5-10Kg). Further altitude changes are given 
in Table 1. Climbers completed an individual itinerary depending on self-declared fitness to 
continue with the ascent profile and rest days taken as required. Subjects recorded daily Lake 
Louise self-reported scores (LLS), AMSc scores, anxiety questionnaires (STAI), SpO2, heart 
rate and HRV via iThlete app. The iThlete app records HRV over a one minute period of timed 
ventilation (20 breaths) to give a number indicating HRV. The heart rate is recorded onto a 
smart phone using the phones’ microphone and a finger probe. This number is based on root 
mean squares of successive differences (RMSSD) of HRV and we have recently published 
the validity of the iThlete app vs. conventional HRV measurement.[7] HRV recording were not 
blinded and were taken by the individual first thing in the morning, in a seated position, before 
food or caffeine wherever possible. Decisions regarding individual fitness to continue with the 
itinerary or climb higher were made regardless of HRV reading (after consultation with a 
medical officer who was also unaware of HRV reading where necessary). Borg Rating of 
Perceived Exertion (RPE) for the “sessional exertion” each day was recorded each evening 
and subjects asked to record their perception as to how hard the hardest bout of exercise that 
day had been (on a scale of 6-20). Reveal Linq cardiac rhythm monitors were inserted into 
members of the climbing team (Reveal LINQ, Medtronic, Dublin, Ireland). These devices were 
inserted by a consultant cardiologist (CB) at Poole Hospital during January 2016. The device 
automatically records any tachycardia, bradycardia or arrhythmia. Baseline data was collected 
automatically via the Carelink system in the UK and downloaded every few days using a larger 
programmer device in Nepal. 
 
 
 
 
 
 
 
 
 
 
  
Table 1. Climbing team Itinerary and altitude changes 
Day Sleeping altitude Activity (evening Location 
0 1400m Arrive Kathmandu 
1 1400m Kathmandu – baseline data collected 
2 848m Beni 
3 2679m Move to Marpha by vehicle 
4 2679m Marpha, subjects free to do own trekking acclimatisation 
5 3720m Trek Alu Bari Lower Camp, 3650m, o/n camp 
6 3720m Alu Bari Lower Camp, 3650m, Acclimatisation day. 
7 4150m Trek Yak Kharta 
8 4150m Yak Kharta, 4600m, acclimatisation day, o/n camp 
9 4150m Yak Kharta, 4600m, acclimatisation day, o/n camp 
10 5140m Trek Hidden Valley 4975m (via Dhampus Pass 5250m) 
10  Hidden Valley, 4975m, acclimatisation day, 
11-24  Hidden Valley basecamp for attempts on Dhampus peak 6035m 
and Tukuche peak 6800m – individual itineraries 
25 4800m Team reduces to 12 and move to Dhaulagiri BC 
26-50  Dhaulagiri BC – individual itineraries. Altitude of 7500m nachieved 
by 5 team members. 
51  Trek to Hidden Valley 
52  Trek to Marpha 
  Rest Marpha 
  Rest Marpha 
  Drive to Pokhara 
  Drive to Kathmandu 
  Fly to UK 
 
 
Trekking teams were invited to take part in studies 580, 578, 586, 623, 624 and 625. 
 
Recruitment and interest in the studies was high. 
 
Trekkers all arrived in Kathmandu by long haul air travel and travelled by road to 1123m before 
attempting a trek of the Dhaulagiri circuit. Each team was accompanied by a medical officer 
who advised on any changes in itinerary based on team or individual acclimatisation. Further 
medical support was available at 3600m, 4650m and 5140m. The itinerary (Table 2) and 
altitude profile (Figure 1) are below. Changes of itinerary where made as necessary when 
trekkers showed signs of acute mountain sickness. Trekkers completed a daily recording of 
LLS, AMSc scores, STAI, SpO2, heart rate. At 3600m, 4650m and 5140m heart rate variability 
was recorded via a Checkmyheart™ HRM device (Daily Care Medical, Naihu, Taiwan). This 
was a conventional single lead ECG and data were downloaded to a laptop to be analysed 
offline by a cardiologist who was blinded to the individuals’ performance and LLS. 
  
Table 2. Trekking team itinerary 
 Activity Sleeping altitude 
Day 1 Fly from UK  
Day 2 Arrive Kathmandu  
Day 3 In Kathmandu. Sightseeing tour  
Day 4 Drive Beni via Pokhara  
Day 5 Drive Darbang and trek Riverside  
Day 6 Trek Jugepani 1456m  
Day 7 Trek Bagar 2017m 
Day 8 Trek Doban 2430m 
Day 9 Trek Sallagari 3107m 
Day 10 Trek Italian BC 3619m 
Day 11 Rest day at Italian BC  
Day 12 Trek to Japanese Camp 4072m 
Day 13 Trek Dhaulagiri Lower BC 4600m 
Day 14 Rest Day, Dhaulagiri Lower BC 4600m 
Day 15 Trek Hidden Valley 5140m 
Day 16 Rest day in Hidden Valley 5140m 
 
 
Results 
 
129 military participants took part in the expedition including 7 research/medical staff. Two 
trekkers were removed from the trail with minor illness before exposure to any significant 
altitude. Three trekkers descended earlier than planned via IBC from higher on the trail; four 
trekkers required extraction from the Hidden Valley by helicopter. One member of the HADT 
withdrew on day 4 of the trek due to non-altitude related illness. Overall, 22 of the remaining 
members of the HADT and main team reached 6035m and five reached 7500m on Dhaulagiri. 
 
AMS was diagnosed by the Lake Louise or AMSc Scores from the daily symptoms scores 
recorded. Subjects were included in analysis with a positive diagnosis of AMS if they took 
drugs to aid acclimatisation or if they were evacuated by helicopter with no symptom scores 
recorded. Data collection was completed well with relatively few missed data collection points. 
The Dhaulagiri circuit is extremely remote and the satellite communication between camps 
was patchy which reduced the ability to trouble shoot and provide rigorous oversight. Specific 
research projects will be analysed individually and results submitted for publication in due 
course. 
 
 
 
 
 
  
Conclusion 
 
The BSDMRE 2016 provided a unique opportunity to perform high quality research projects 
in the most challenging and austere of situations. Strong collaboration between civilian 
universities and military personnel drew on specialist expertise, maximised funding 
opportunities and enabled a range of projects to be completed. The combination of AT and 
research on an exercise of this scale was a novel undertaking and organisationally challenging 
but will result in significant and militarily relevant outputs. After the enduring operations of 
TELIC and HERRICK research strategies must now focus on support of the wider military as 
we return to contingency. Remote, mountainous environments remain a safe haven for 
potential enemies and presents significant challenges for non-acclimatised troops operating 
in those areas. BSDMRE ranks as one of the largest participation HA research expeditions 
ever conducted and continues a tradition of military leadership in this field. 
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Fig 1. Altitude profile for trekking teams 
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